E
Elaine Liversidge
Researcher at Eastman Kodak Company
Publications - 22
Citations - 1271
Elaine Liversidge is an academic researcher from Eastman Kodak Company. The author has contributed to research in topics: Nanoparticle & Particle size. The author has an hindex of 12, co-authored 22 publications receiving 1270 citations. Previous affiliations of Elaine Liversidge include Merck & Co. & Bosch.
Papers
More filters
Patent
Surface modified anticancer nanoparticles
TL;DR: Dispersible particles consisting essentially of a crystalline anticancer agent having a surface modifier adsorbed on the surface thereof in an amount sufficient to maintain an effective average particle size of less than about 1000 nm as mentioned in this paper.
Patent
Sulfated nonionic block copolymer surfactants as stabilizer coatings for nanoparticle compositions
Sui-Ming Wong,Ian M. Newington,Elaine Liversidge,Gregory L. McIntire,Alan R. Pitt,Jack Michael Shaw +5 more
TL;DR: In this paper, a block copolymer linked to at least one anionic group as a surface modifier is used as an adaption on the surface of the nanoparticles.
Patent
Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions
TL;DR: In this article, the authors describe an insoluble organic drug and at least one polyethylene glycol-derivatized lipid adsorbed on the surface of the drug.
Patent
Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions
TL;DR: In this article, methods of intravenous administration of nanoparticulate drug formulations to a mammal to avoid adverse hemodynamic effects were discussed. But none of these methods are suitable for humans.
Patent
Nanoparticulate formulations of docetaxel and analogues thereof
TL;DR: In this paper, the authors described a class of nanoparticulate docetaxel or analogue thereof compositions, which can be used in the treatment of cancer, and described a set of surface stabilizers.